Hadron Energy (HDRN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
5 Oct, 2026Executive summary
Q1 activity remained limited to formation, the 2024 offering and business-combination search; no specific target had been selected as of March 31, 2025. No operating revenue is expected before a combination.
The initial business combination must be completed within 21 months of the August 30, 2024 offering closing.
Financial highlights
Q1 net income was $1,618,274, with operating expenses of $371,833 and warrant fair-value expense of $114,173, offset by $2,103,979 of Trust Account interest and $301 of operating-account interest.
No operating revenue was generated; basic and diluted EPS were $0.05 for both redeemable Class A and non-redeemable Class B shares.
Cash outside the Trust Account was $926,474 at March 31, 2025, versus $1,344,228 at December 31, 2024; Q1 operating cash use was $417,754.
Outlook and guidance
Acquisition-related due diligence and public-company compliance costs are expected to increase; operating revenue is not expected until after a business combination.
If outside-trust funds are insufficient for at least 12 months of operations, cash outlays may be managed by timing expenses or seeking Sponsor funding; additional financing may not be available on acceptable terms.
Substantially all Trust Account funds, net of applicable taxes, are intended for a target acquisition and related expenses; remaining funds may support the acquired business after closing.
Latest events from Hadron Energy
- Higher costs cut Q1 net income; merger closing hinges on cash, approvals and redemptions.HDRN
Q1 2026 - A $250 million blind-pool IPO pairs a 21-month deadline with steep dilution and conflicts.HDRN
Registration filing - A $250 million SPAC raise pairs a 24-month acquisition search with substantial dilution and conflicts.HDRN
Registration filing - IPO proceeds reached $200.0 million; a business-combination target remains unselected.HDRN
Q3 2024 - Trust interest drove SPAC income as the microreactor target remained loss-making and pre-commercial.HDRN
Q4 2025 - 25M-unit IPO filing amended solely to add exhibits, with a 3.75M-unit option.HDRN
Registration filing - Trust income drove earnings, but no target and limited operating cash sustain execution risk.HDRN
Q2 2025 - $250M SPAC, no target selected, 24-month deadline and material dilution risks.HDRN
Registration filing - A microreactor commercialization plan meets a large resale overhang and acute funding risk.HDRN
Registration filing